Your session is about to expire
← Back to Search
ONE TEAM Trial Summary
This trial will test a new way of managing care for cancer patients with comorbidities. 800 patients will be randomly assigned to either usual care or care that includes their primary care physician as an active member of their cancer care team. The goal is to improve chronic disease management and communication among cancer survivors.
ONE TEAM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowONE TEAM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ONE TEAM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on my first or second treatment for CLL or SLL.I am a man with prostate cancer currently receiving hormone therapy.I had an organ transplant, but my kidney function is normal.I am currently on medication for either hypertension, diabetes, or high cholesterol.I am 65 or older, have a heart condition, and had cancer surgery at DUHS between 2017 and 2019.I can stay in the study if my cancer spreads, unless I choose to leave.I have been diagnosed with uterine sarcoma.You have seen your primary care doctor in the last 12 months.I am having surgery at Duke but won't return for follow-up.I am an English-speaking primary care physician who has cared for older adults post-cancer surgery at DUHS within the last year.My heart is weak, functioning below 30% efficiency.I have been diagnosed with early to mid-stage cancer in specific areas or any stage of prostate cancer.My treatment was aimed at curing my cancer, not just relieving symptoms.I have had a heart attack in the last 2 years.I was asked to join the study within 4 months of starting my cancer treatment at Duke, except if I'm on ADT for prostate cancer.I am between 18 and 79 years old.I have had surgery to remove lymph nodes under both arms.My kidney function is severely reduced.I have a neuroendocrine tumor.
- Group 1: iGuide Intervention
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do you accept individuals aged 35 and older into this research project?
"In compliance with the stipulated eligibility criteria, individuals must be between 18 and 79 years old to participate in this clinical trial."
What is the size of the patient cohort participating in this experiment?
"Affirmative. According to clinicaltrials.gov, the medical trial posted on June 14th 2021 is actively recruiting candidates. 800 patients are required from a single centre for this study which was most recently updated on May 20th 2022."
What are the objectives of this experiment?
"This 18 month clinical trial aims to assess the HEDIS quality measure of diabetes management. Secondary objectives include evaluating patient activation, provider-reported care coordination, and financial burden. To evaluate patient activation, researchers will use the Patient Activation Measure (PAM), which is a 13-item test that places patients into four levels based on their knowledge, skills, and confidence in managing health conditions. Provider-reported care coordination will be evaluated using two separate surveys: The Coordination of Specialty Care - Specialist Survey (13 items) and the Coordination of Specialty Care - Primary Care Survey (24 items). Finally, financial burden or '"
Does my profile satisfy the criteria necessary to join this research endeavor?
"This clinical trial specifically seeks 800 individuals with hypertension aged between 18 and 79. For eligibility, participants must have had a physical check-up within the past 12 months, alongwith having at least one of three comorbid cardiovascular diseases (hypertension, diabetes or hypercholesterolemia). In addition to these applicants, 2800-3000 patients will be selected from Duke Cancer Registry who are over 65 years old and possess any of the aforementioned CVDs. These selected retrospective cohorts will then proceed on cancer surgery for solid tumors such as breast, prostate and colorectal cancers before December 31st 2019."
Are there any enrollment opportunities for this experiment currently available?
"Exactly, the data accessible through clinicaltrials.gov portrays this medical trial as actively seeking volunteers. It was initially published on June 14th 2021 and has been recently amended on May 20th 2022. 800 participants are in need of recruitment from a single location."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger